A phase 3 trial subgroup analysis found that adding pembrolizumab to adjuvant chemotherapy may improve disease-free survival in patients with mismatch repair-deficient endometrial cancer, a population at...
A randomized trial found that radiation therapy alone provides better progression-free survival and fewer acute toxicities than chemoradiation for women with localized recurrent endometrial cancer.
A randomized clinical trial found that while low-magnitude mechanical signals did not improve trabecular bone mineral density in adolescents with anorexia nervosa, it significantly increased tibial bone...
A new study outlines key barriers and facilitators to adopting a clinical practice guideline aimed at improving perinatal pain management and identifies strategies and tools to support implementation in...
New findings from the Women’s Health Initiative trials provide long-term insights into the effects of hormone therapy regimens on ovarian and endometrial cancer incidence and mortality.
A large multicenter study suggests that artificial intelligence-supported mammography screening can improve breast cancer detection rates without increasing recall rates, addressing key challenges in...
A recent study assessed cervical cancer mortality trends among US women younger than 25 from 1992 to 2021, highlighting changes in mortality rates following the widespread use of the HPV vaccine.
Researchers developed a cross-sectional survey to understand the public and provider awareness of postmenopausal bleeding as a symptom of endometrial cancer.
In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.
